Virtus LifeSci Biotech Clinical Tri... (BBC)
$28.16
-0.37 (-1.28%)
Rating:
Recommendation:
-
Symbol | BBC |
---|---|
Price | $28.16 |
Beta | 0.000 |
Volume Avg. | 0.00M |
Market Cap | 28.574M |
Shares () | - |
52 Week Range | 17.77-31.675 |
1y Target Est | - |
DCF Unlevered | BBC DCF -> | |
---|---|---|
DCF Levered | BBC LDCF -> | |
ROE | - | |
ROA | - | |
Operating Margin | - | |
Debt / Equity | - | |
P/E | - | |
P/B | - |
Latest BBC news
About
Download (Excel)Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering ("lead drug") that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval.